Provided by Tiger Trade Technology Pte. Ltd.

Orchestra BioMed

5.78
-0.2300-3.83%
Post-market: 5.950.1700+2.94%19:54 EDT
Volume:411.20K
Turnover:2.41M
Market Cap:346.11M
PE:-5.78
High:6.26
Open:6.03
Low:5.73
Close:6.01
52wk High:6.28
52wk Low:2.20
Shares:59.88M
Float Shares:33.00M
Volume Ratio:0.96
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9995
EPS(LYR):-1.1091
ROE:-397.30%
ROA:-45.73%
PB:17.91
PE(LYR):-5.21

Loading ...

Orchestra BioMed Says Investigational AVIM Hypertension Therapy Features in HRX Live Sessions

Reuters
·
Sep 16

Orchestra Biomed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics

THOMSON REUTERS
·
Sep 15

Press Release: Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics

Dow Jones
·
Sep 15

B. Riley Adjusts Orchestra BioMed Price Target to $11 From $10, Maintains Buy Rating

MT Newswires Live
·
Sep 15

Orchestra BioMed Shares Rise After BTIG Upgrade

MT Newswires Live
·
Sep 11

Top Midday Gainers

MT Newswires Live
·
Sep 11

BTIG Upgrades Orchestra BioMed to Buy From Neutral, Price Target is $10

MT Newswires Live
·
Sep 10

Orchestra Biomed Holdings Inc : Btig Raises to Buy from Neutral

THOMSON REUTERS
·
Sep 10

Orchestra BioMed Holdings Price Target Announced at $10.00/Share by BTIG

Dow Jones
·
Sep 10

Top Exec Makes Bold Insider Move at Orchestra BioMed Holdings

TIPRANKS
·
Sep 09

Orchestra BioMed Highlights $500 Million-Plus Annual Royalty Potential from Medtronic-Partnered AVIM Pacemaker Therapy

Reuters
·
Sep 08

Orchestra BioMed CEO, Chair David P. Hochman Buys $47,900 Common Shares

Reuters
·
Sep 08

Orchestra BioMed COO, Director Darren Sherman Disposes of 15,000 Common Shares for $74,100

Reuters
·
Sep 03

Orchestra BioMed Grants 133,000 Inducement Stock Options to Seven New Hires Under 2025 Plan

Reuters
·
Sep 03

Orchestra Biomed Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 03

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 03

Orchestra BioMed COO Darren Sherman Reports Acquisition of 2,000 Common Shares Valued at $10,660

Reuters
·
Aug 29

Orchestra BioMed CEO Hochman Presents at H.C. Wainwright Global Investment Conference

Reuters
·
Aug 27

Orchestra BioMed CEO Hochman Presents at Wells Fargo Healthcare Conference

Reuters
·
Aug 20

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
Aug 13